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A Case of Piperacillin-induced Occupational Anaphylaxis: 
Detection of Serum IgE to Piperacillin-HSA Conjugate
This is the first reported detection of serum IgE antibody to piperacillin-human serum 
albumin (HSA) conjugate in a patient presenting with anaphylaxis that developed after 
occupational exposure. A 24-yr-old nurse, who had worked at a University Hospital for     
2 yr, experienced chest tightness, dizziness, generalized urticaria, abdominal pain, and 
diarrhea 10 min after administering a piperacillin injection. She had previously suffered 
from atopic dermatitis. A skin prick test for common inhalant allergens was entirely 
negative; in contrast, her serum total IgE was elevated (283 IU/mL). A high level of 
piperacillin-specific serum IgE was detected by ELISA using piperacillin-HSA conjugate. 
Significant inhibition upon addition of both free piperacillin and piperacillin-HSA conjugate 
was detected by inhibition ELISA. These data suggest that piperacillin exposure in the 
workplace can induce occupational anaphylaxis and urticaria mediated by an interaction 
of IgE with the hapten of piperacillin.
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CASE REPORT
Immunology, Allergic Disorders & Rheumatology
INTRODUCTION
Piperacillin is an extended-spectrum beta-lactam antibiotic of 
the ureidopenicillin family. Piperacillin is widely used in con-
junction with tazobactam, a beta-lactamase inhibitor. Some 
penicillins have been reported to cause occupational diseases, 
including bronchial asthma (1, 2), anaphylaxis (3), contact urti-
caria (4), contact dermatitis (5), and hypersensitivity pneumo-
nitis (6), in pharmaceutical workers and health care profession-
als. Most of these penicillins belong to the benzylpenicillin or 
aminopenicillin family. Occupational contact urticaria and ana-
phylaxis induced by cephalosporins have often been reported 
(7). With regard to piperacillin, there is only one published re-
port of occupational asthma, rhinitis, and urticaria in a pharma-
ceutical worker (1). However, to our knowledge, there has been 
no report of occupational anaphylaxis induced by piperacillin. 
Furthermore, no evidence of a serum IgE antibody response to 
piperacillin has been published. This is thus the first report of 
occupational anaphylaxis due to piperacillin and detection of a 
serum IgE response to a piperacillin-HSA conjugate.
CASE DESCRIPTION
The subject was a 24-yr-old female nurse who worked in the in-
tensive care unit at a University Hospital. She had handled piper-
acillin/tazobactam without gloves or a mask since March 2003. 
Eighteen months later (October 2004), she experienced gener-
alized urticaria with onset immediately and repeatedly after she 
had administered piperacillin. Nevertheless, she continued to 
work and finally experienced chest tightness, dizziness, sweat-
ing, generalized urticaria, abdominal pain, and diarrhea 10 min 
after giving a piperacillin injection in April 2005. Her blood pres-
sure was 80/50 mmHg with a pulse rate of 104 beats/min. Her 
breath sounds were clear. The symptoms resolved completely 
after treatment with epinephrine, diphenhydramine, and meth-
ylprednisolone. She had a previous history of atopic dermatitis, 
and her hand eczema had become exacerbated after she had 
begun to work at the hospital.
Skin prick tests and measurement of serum total IgE
Skin prick tests using 80 common inhalant and food allergens 
(Bencard, Brentford, UK) were all negative. We did not perform 
a skin prick test with piperacillin/tazobactam because of the risk 
of anaphylaxis (8). Serum total IgE, measured using an immuno-
CAP
® system (Phadia, Uppsala, Sweden), was 283 IU/mL.
Assay of serum IgE and IgG levels
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piperacillin-human serum albumin (HSA) conjugates in our 
laboratory and performed an ELISA as described previously (11). 
Piperacillin-specific IgE and IgG levels in an initial serum sam-
ple and the IgE level in a serum sample obtained 5 yr later (May 
2010) were measured. In brief, the wells of a 96-well ELISA mi-
croplate (Corning, New York, NY, USA) were coated by incuba-
tion with piperacillin-HSA conjugate at 10 μg/mL in phosphate-
buffered saline (PBS) overnight at 4°C. After the wells were washed 
four times with 350 μL of PBS containing 0.05% Tween 20 (PBS-
T; Sigma-Aldrich, St. Louis, MO, USA), nonspecific binding sites 
were blocked by incubation with 200 μL of 10% fetal bovine se-
rum (FBS; GIBCO/Invitrogen, Carlsbad, CA, USA) in PBS at room 
temperature for 2 hr. After washing four times with 0.05% PBS-T, 
50 μL of diluted serum (1:3) were added to each well, followed 
by incubation for 2 hr at 37°C. The plate was washed four times 
with 0.05% PBS-T, then 100 μL of goat anti-human IgE antibody 
(Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD, USA) 
diluted 1:1,000 with 10% FBS-PBS were added to each well, and 
the plate was incubated for 1 hr at room temperature. After wash-
ing four times with 0.05% PBS-T, 100 μL of alkaline phosphate-
conjugated rabbit anti-goat IgG antibody (ReserveAPTM; Kirkeg-
aard & Perry Laboratories) diluted 1:500 with 10% FBS-PBS were 
added to each well, and the plate was incubated for 1 hr at room 
temperature. PNPP (p-nitro-phenyl phosphate; Sigma-Aldrich) 
substrate was added, and the reaction was stopped by the addi-
tion of 1 N NaOH. The optical density of the solution in each well 
was measured at 405 nm using a microplate reader (Synergy HT; 
Bio-Tek, Winooski, VT, USA). The final absorbance value of piper-
acillin was determined by subtracting the absorbance value of 
a control crosslinker-HSA conjugate, which was obtained using 
a procedure identical to that described above, except that a cross-
linker-HSA conjugate was used in place of piperacillin-HSA con-
jugate. The positive cutoff value was determined as the mean 
plus three standard deviations of the absorbance values in se-
rum samples from 11 unexposed, non-atopic healthy controls. 
For the inhibition ELISA, increasing amounts (1-100 μg/mL) of 
free piperacillin, piperacillin-HSA conjugate, and HSA alone, dis-
solved in 10% FBS-PBS, were incubated with serum overnight, 
and an ELISA was performed as described above. The percent-
age inhibition was calculated as follows: % inhibition = (1 − ab-
sorbance with inhibitor/absorbance without inhibitor) × 100. 
For the ELISA of piperacillin-specific serum IgG levels, alkaline 
phosphate-conjugated rabbit anti-human IgG antibody (Kirkeg-
aard & Perry Laboratories) was used instead of goat anti-human 
IgE antibody and alkaline phosphate-conjugated rabbit anti-goat 
IgG antibody. A high level of specific IgE antibody to piperacil-
lin-HSA conjugate was detected in the initial serum sample from 
the subject; however, this had decreased markedly after 5 yr (Fig. 
1). Significant inhibition by both free piperacillin and piperacil-
lin-HSA conjugate occurred in a dose-dependent manner, with 
minimal inhibition by HSA alone (Fig. 2). High levels of piper-
acillin-HSA conjugate-specific IgG were also detected in the 
initial serum sample (data not shown).
  Based on these findings, the subject was diagnosed with oc-
cupational anaphylaxis and urticaria caused by piperacillin. The 
subject was transferred to a different department and has not 
again experienced anaphylaxis or urticaria. 
DISCUSSION
Although we did not perform provocation and skin prick tests 
with piperacillin, we diagnosed this patient with occupational 
anaphylaxis because: 1) the temporal correlation between han-
dling piperacillin and anaphylaxis; 2) a history of recurrent urti-
caria after handling piperacillin; and 3) detection of piperacil-
lin-specific IgE in the serum. The complete disappearance of 
anaphylaxis and the reduction of serum IgE after avoidance of 
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Fig. 1. Measurement of piperacillin specific IgE antibodies by inhibition ELISA. Levels 
of specific IgE to piperacillin-human serum albumin (HSA) conjugate in patient serum 
(●), collected at the initial visit (A) and after 5 yr’ avoidance (B) and in sera from un-
exposed, non-atopic healthy control subjects (○). Horizontal bars indicate the cut-off 
values (mean plus three standard deviations of the absorbance values of controls). 
Fig. 2. Effect of piperacillin-HSA conjugate (●), free piperacillin (○), or HSA only (▲) 
in an inhibition ELISA. Both piperacillin-HSA conjugate and free piperacillin showed 
significant inhibition.
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piperacillin further support this diagnosis. These findings sug-
gest that occupational exposure to piperacillin induced IgE-me-
diated anaphylaxis in this subject. 
  Piperacillin can induce allergic reactions such as bronchial 
asthma, rhinitis (1), urticaria, anaphylaxis (9, 12), immune he-
molytic anemia (10), maculopapular exanthem (13, 14), acute 
generalized exanthematous pulstulosis (15), and drug hypersen-
sitivity syndrome (16). Several reports used skin prick, provoca-
tion, and serologic tests to demonstrate that piperacillin induced 
these reactions (1, 9, 10). A previous study reported that two of 
311 tertiary hospital nurses showed a positive skin prick test to 
piperacillin (0.6%) (17). Two studies attempted to measure piper-
acillin-specific IgE levels in serum (1, 9). One involved a case of 
anaphylaxis, urticarial, and angioedema after intravenous piper-
acillin injection in an acute bronchitis patient, and the other was 
a case of occupational asthma, rhinitis, and urticaria induced 
by piperacillin powder exposure in a pharmaceutical worker. In 
those reports, a radioisotope test was used to detect IgE levels, 
but the assay failed. In the present study, we successfully de-
tected piperacillin-HSA conjugate-specific serum IgE by ELISA 
in a patient with suspected piperacillin-induced occupational 
anaphylaxis. Furthermore, the binding specificity of the IgE was 
confirmed by inhibition ELISA. As significant inhibition by both 
free piperacillin and piperacillin-HSA conjugate was detected, 
it is likely that the hapten component of piperacillin is the anti-
genic determinant. High serum piperacillin-HSA conjugate-spe-
cific IgG levels were also detected in this patient, while levels in 
controls were minimal (data not shown). Although one study 
has sought to evaluate penicillin-specific IgG levels in the sera 
of patients with penicillin allergies, the significance of IgG levels 
remains unclear (18). Further studies are needed to investigate 
the role of specific IgG or its subclasses in occupational allergic 
diseases induced by piperacillin.
  Nontherapeutic exposure to antibiotics, including penicillins, 
can occur by various routes (3). Contact with spilled drugs and 
inhalation of powder or foam are the most common routes. Ex-
posure by the contact route usually induces contact urticaria (4), 
anaphylaxis (19), or dermatitis (5), whereas the inhalation route 
induces most commonly asthma or rhinitis (2, 20). Inhalation 
can also induce urticaria (1). Piperacillin, an intravenous antibi-
otic, is provided as a powder in a bottle and should be dissolved 
prior to administration. When dissolved, piperacillin develops 
little foam, but emits a more obvious odor than other intrave-
nous antibiotics. The subject in the present report sometimes 
suffered from urticaria without direct contact with the solution, 
suggesting that inhalation of evaporated piperacillin may be the 
major route of sensitization. However, considering the reported 
exacerbation of hand eczema that occurred prior to the anaphy-
laxis, we speculate that exposure by direct contact with piperacil-
lin solution may also have been a factor.
  In conclusion, we report a case of a nurse with anaphylaxis 
and generalized urticaria caused by piperacillin and mediated 
by an interaction of IgE with the hapten of piperacillin. Sensiti-
zation was suspected to have occurred through inhalation of 
piperacillin vapor. Given that an ELISA was capable of detect-
ing piperacillin-specific serum IgE, this system could be used 
for detecting piperacillin-HSA conjugate-specific IgE in the se-
rum of occupational anaphylaxis or asymptomatic sensitized 
patients.
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